Satoshi Nakagawa

9PUBLICATIONS
82CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Disease surveillancePredictive and prognostic markersPreventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 20, 2025
VRK1 Is a Novel Therapeutic Target for Small Cell Neuroendocrine Carcinoma of the Cervix.

Mariya Kobayashi, Satoshi Nakagawa, Yusuke Ishii

|Aug 14, 2025
Effect of Immersive Virtual Reality on Chemotherapy-Related Side Effects in Patients Receiving Paclitaxel-Carboplatin With or Without Bevacizumab: 2-Arm Randomized Controlled Trial.

Kazuyuki Niki, Satoshi Nakagawa, Misaki Arai

|Jul 31, 2025
The value of vaginal cytology for postoperative surveillance of endometrial cancer.

Yuko Watanabe, Eiji Kobayashi, Tatsuo Masuda

|Jul 01, 2025
Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma: the Asian cohort of the AtTEnd/ENGOT-EN7 trial.

Kenichi Harano, Roldano Fossati, Beatriz Pardo

|Feb 09, 2025
Prognostic significance of para-aortic node metastasis in endometrial cancer: Japanese Gynecologic Oncology Group Study JGOG2043 post hoc analysis.

Yosuke Konno, Michinori Mayama, Kazuhiro Takehara

|Jul 12, 2024
Estimation of self-funded human papillomavirus vaccine recipients from Japan's previously assumed "unvaccinated generation".

Mariya Kobayashi, Satoshi Nakagawa, Yutaka Ueda

Pageof 2

Frequent Collaborators

4 joint publications

Yutaka Ueda

3 joint publications

Kazuhiro Takehara

3 joint publications

Kosuke Hiramatsu

3 joint publications

Kenichi Harano